Imatinib mesylate and treatment of chronic myeloid leukemia

被引：0
|
作者：
Yamada, Hisashi [1 ]
机构：
[1] Jikei Univ, Sch Med, Inst DNA Med, Minato Ku, Tokyo 1058461, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：39P / 39P
页数：1
相关论文
共 50 条
  • [41] FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE
    Eskazan, A. E.
    Baslar, Z.
    Ayer, M.
    Kantarcioglu, B.
    Arica, D.
    Demirel, N.
    Aydin, D.
    Yalniz, F. F.
    Elverdi, T.
    Salihoglu, A.
    Ar, M. C.
    Aydin, S. Ongoren
    Aydin, Y.
    Tuzuner, N.
    Ozbek, U.
    Soysal, T.
    HAEMATOLOGICA, 2014, 99 : 330 - 331
  • [42] Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase
    Kiguchi, Toru
    Tauchi, Tetsuzo
    Ito, Yoshikazu
    Miyazawa, Keisuke
    Kimura, Yukihiko
    Ohyashiki, Kazuma
    LEUKEMIA RESEARCH, 2009, 33 (03) : 506 - 508
  • [43] Imatinib mesylate in chronic myeloid leukemia of childhood: From care to cure?
    Warrier, Arun
    Santa, Ayyagari
    Sagar, T. G.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 577 - 577
  • [44] Imatinib mesylate can induce molecular remissions in chronic myeloid leukemia
    Lawler, M
    Gately, K
    Ryan, J
    Carroll, P
    Howard, J
    Stallings, R
    Conneally, E
    McCann, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S160 - S160
  • [45] Drug Efflux Transporters and Imatinib Mesylate Insensitivity in Chronic Myeloid Leukemia
    Aquino Moreira-Nunes, Caroline Fatima
    Simoes Beltrao, Ana Cristina
    Valente Martins Frances, Larissa Tatiana
    Mattos Amaral Sousa, Rodrigo Guarischi
    Silva, Israel Tojal
    Silva, Artur Luiz
    Silva-, Wilson Araujo, Jr.
    Rodrigues Lemos, Jose Alexandre
    BLOOD, 2012, 120 (21)
  • [46] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
  • [47] Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel
    Yamazaki, Rie
    Aisa, Yoshinobu
    Mori, Takehiko
    Iketani, Osamu
    Ikeda, Yasuo
    Okamoto, Shinichiro
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 670 - 672
  • [48] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
  • [49] Lichen planus in a patient with chronic myeloid leukemia taking imatinib mesylate
    Carneiro de Castro, Carlos Gustavo
    dos Santos, Aline Sarkis
    Meotti, Carolina Degen
    Gama, Carolina Mendonca
    Silveira, Luisa Kelmer
    Serafini, Natalia Battisti
    Pereira, Raquel Noschang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB205 - AB205
  • [50] Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
    Hu, Zheng
    Pan, Xiao-Fen
    Wu, Fu-Qun
    Ma, Li-Yuan
    Liu, Da-Peng
    Liu, Ying
    Feng, Ting-Ting
    Meng, Fan-Yi
    Liu, Xiao-Li
    Jiang, Qian-Li
    Chen, Xiao-Qin
    Liu, Jing-Lei
    Liu, Ping
    Chen, Zhu
    Chen, Sai-Juan
    Zhou, Guang-Biao
    PLOS ONE, 2009, 4 (07):
12345